# Photodynamic Therapy in Treating Patients With Early Esophageal Cancer

> **NCT00002935** · PHASE2 · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 30 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** porfimer sodium

## Key facts

- **NCT ID:** NCT00002935
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-10
- **Primary completion:** 2006-08
- **Final completion:** 2007-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2011-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002935, "Photodynamic Therapy in Treating Patients With Early Esophageal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00002935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*